The UK's Permanent Secretary of Department of Health Una O’Brien recently led a health care mission to India, leading to a number of partnerships and MOUs between the two countries.
Public Health England (PHE), an executive agency of the Department of Health, signed MOUs with the Public Health Foundation of India (PHFI), and with the Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER – see photo) which is an institution of national importance. One of the first joint initiatives is to establish the epidemiology of Crimean-Congo Haemorrhagic Fever (CCHF) in India and cost effectiveness of potential interventions.
PHE chief executive Duncan Selbie said: “PHE is delighted to announce this program of work with Indian partners to tackle global public health issues. Our scientists have developed a CCHF vaccine candidate, which is the only one so far to show complete protection in an animal model.”
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze